Background Expanding treatment for hypertension requires ensuring access to affordable, high-quality blood pressure (BP) lowering medications. We describe the design, implementation and evaluation of ...

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

The CNPV program aims to reduce drug review times to 1-2 months, raising concerns about safety and regulatory scrutiny. Critics argue that accelerated timelines may lead to safety issues and strain ...

Medicaid provides health coverage for disabled and low-income populations, and the ACA expansion gives states the option to extend coverage to adults with up to 138% of the federal poverty line.

European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg ...

Richardson, who spent just 33 games with the Warriors, was banned in 1986 after violating the league’s drug policy for cocaine use.

TCT 671: From Transfer to Retention: In-Vivo OCT Insights into Crystalline Sirolimus Behavior After Drug-Coated Balloon Angioplasty in De Novo Lesions Receive the the latest news, research, and ...

It’s possible to produce a generic version of lenacapavir, a twice-yearly antiretroviral injection that both prevents and treats HIV, for as little as $25 per patient per year, according to a study ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

Let's say you fall in love with someone harboring a deadly -- and highly infectious -- virus. And you think … is it crazy to get married? Sometimes love conquers all — with the help of modern medicine ...